Antibiotic Prescribing in Critical Care: General Principles

Hanberger H Diekema D Fluit A Surveillance of antibiotic resistance in European ICUs. J Hosp Infect 2001; 48: 161–76.

Fridkin SK Gaynes RP . Antimicrobial resistance in intensive care units. Clin Chest Med 1999; 20: 303–316.

Raveh D Rudensky B Schlesinger Y Susceptibility trends in bacteremias: analyses of 7,544 patient-unique bacteremic episodes spanning eleven years (1990–2000). J Hosp Infect 2003; 55: 196–203.

Vincent J-L Bihari D Suter PM . The prevalence of noscocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) study. JAMA 1995; 274: 639–44.

Geissler A Gerbeaux P Granier I Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs. Intensive Care Med 2003; 29: 49–54.

Zillich AJ Sutheraland JM Wilson SJ Antimicrobial use control measures to prevent and control antimicrobial resistance in US hospitals. Infect Control Hosp Epidemiol 2006; 27: 1088–95.

Bodi M Rodriguez A Sole-Violen J Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival. Clin Infect Dis 2005; 41: 1709–16.

Shorr AF Bodi M Rodriguez A ; CAPUCI Study Investigators. Impact of antibiotic guideline compliance on duration of mechanical ventilation in critically ill patients with community-acquired pneumonia. Chest 2006; 130: 93–100.

National Audit Office. The management and control of hospital acquired infection in acute NHS trusts in England. Feb 2000.

Ebert SC . Application of Pharmacokinetics and Pharmacodynamics to Antibiotic Selection. P&T 2004; 29: 244–250. www.ptcommunity.com/ptjournal/fulltext/29/4/ptj904244.pdf.

Zhanel GG Ennis K Vercaigne L A critical review of the fluoroquinolones: focus on respiratory infections. Drugs 2002; 62: 13–59.

Gotfried MH Danziger LH Rodvold KA . Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects. Chest 2001; 119: 1114–22.

Mattie H Craig WA Pechere JC . Review: determinants of efficacy and toxicity of aminoglycosides. J Antimicrob Chemother 1989; 24: 281–293.

Fisman DN Kaye KM . Once-daily dosing of aminoglycoside antibiotics. Infect Dis Clin North Am. 2000 14: 475–87.

Ebert SC Craig WA . Pharmacodynamic properties of antibiotics: application to drug monitoring and dosage regimen design. Infect Control Hosp Epidemiol 1990; 11: 319–26.

Frei CR Burgess DS . Continuous infusion β-lactams for intensive care unit pulmonary infections. Clinical Microbiology and Infection 2005; 11: 418–420.

Grant EM Kuti JL Nicolau DP Clinical efficacy and pharmacoeconomics of a continuous-infusion piperacillin-tazobactam program in a large community teaching hospital. Pharmacotherapy 2002; 22: 471–83.

Bodey GP Ketchel SJ Rodriguez V . A randomised study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients. Am J Med 1979; 67: 608–16.

MacGowan AP Bowker KE . Continuous infusion of β-lactam antibiotics. Clinical Pharmacokinetics 1998; 35: 391–402.

Wysocki M Delatour F Faurisson F Continuous versus Intermittent Infusion of Vancomycin in Severe Staphylococcal Infections: Prospective Multicentre Randomised Study. Antimicrob Agents Chemother. 2001; 45: 2460–2467.

Kollef MH Sherman G Ward S Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999; 115: 462–474.

Leone M Garcin F Bouvenot J Ventilator-associated pneumonia: breaking the vicious circle of antibiotic overuse. Crit Care Med 2007; 35: 379–85.

Richards MJ Edwards JR Culver DH Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 1999; 27: 887–92.

Markowicz P Wolff M Djedaini K Multicentre prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome. Am J Respir Crit Care Med 2000; 161: 1942–8.

Husni RN Goldstein LS Arroliga AC Risk factors for an outbreak of multi-drug-resistant Acinetobacter nosocomial pneumonia among intubated patients. Chest 1999; 115: 1378–82.

Edgeworth JD Treacher DF Eykyn SJ . A 25-year study of nosocomial bacteremia in an adult intensive care unit. Crit Care Med 1999; 27: 1421–8.

Hoffken G Niederman MS . The importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU. Chest 2002; 122: 2183–96.

Kollef MH . Optimising antibiotic therapy in the intensive care unit setting. Crit Care 2001; 5: 189–195.

Gruson D Hilbert G Vargas F Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of gram-negative bacilli responsible for ventilator-associated pneumonia. Crit Care Med 2003; 31: 1908–14.

Hughes MG Evans HL Chong TW Effect of an intensive care unit rotating empiric antibiotic schedule on the development of hospital-acquired infections on the non-intensive care unit ward. Crit Care Med 2004; 32: 53–60.

Van Loon HJ Vriens MR Fluit AC Antibiotic rotation and development of gram-negative antibiotic resistance. Am J Respir Crit Care Med 2005; 171: 480–7.

Damas P Canivet JL Ledoux D Selection of resistance during sequential use of preferential antibiotic classes. Intensive Care Med 2006; 32: 67–74.